gadolinium has been researched along with Pseudomyxoma Peritonei in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barone, RM; Gurney, JM; Low, RN; Muller, WD | 1 |
| Alzate, GD; Barone, RM; Lacey, C; Low, RN; Sebrechts, CP; Sigeti, JS | 1 |
2 other study(ies) available for gadolinium and Pseudomyxoma Peritonei
| Article | Year |
|---|---|
Mucinous appendiceal neoplasms: preoperative MR staging and classification compared with surgical and histopathologic findings.
Topics: Adult; Aged; Aged, 80 and over; Appendiceal Neoplasms; Contrast Media; Female; Gadolinium; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasm Staging; Peritoneal Neoplasms; Predictive Value of Tests; Pseudomyxoma Peritonei; Retrospective Studies | 2008 |
Peritoneal tumor: MR imaging with dilute oral barium and intravenous gadolinium-containing contrast agents compared with unenhanced MR imaging and CT.
Topics: Administration, Oral; Barium Sulfate; Contrast Media; Drug Combinations; Female; Gadolinium; Gadolinium DTPA; Glucagon; Humans; Image Processing, Computer-Assisted; Injections, Intravenous; Magnetic Resonance Imaging; Male; Meglumine; Middle Aged; Organometallic Compounds; Pentetic Acid; Peritoneal Neoplasms; Prospective Studies; Pseudomyxoma Peritonei; Sensitivity and Specificity; Tomography, X-Ray Computed | 1997 |